Petmed Express Stock Today

PETS Stock  USD 4.15  0.10  2.47%   

Performance

0 of 100

 
Weak
 
Strong
Very Weak

Odds Of Distress

Less than 18

 
High
 
Low
Low
PetMed Express is selling for under 4.15 as of the 24th of April 2024; that is 2.47 percent increase since the beginning of the trading day. The stock's lowest day price was 4.05. PetMed Express has less than a 18 % chance of experiencing some financial distress in the next two years of operation, but has generated negative returns over the last 90 days. Equity ratings for PetMed Express are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 5th of May 2022 and ending today, the 24th of April 2024. Click here to learn more.
Business Domain
Consumer Discretionary Distribution & Retail
IPO Date
26th of April 1999
Category
Healthcare
Classification
Consumer Discretionary
PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. PetMed Express, Inc. was incorporated in 1996 and is headquartered in Delray Beach, Florida. Petmed Express operates under Pharmaceutical Retailers classification in the United States and is traded on NASDAQ Exchange. The company has 21.15 M outstanding shares of which 4.9 M shares are at this time shorted by private and institutional investors with about 14.32 trading days to cover. More on PetMed Express

Moving together with PetMed Stock

  0.88DXLG Destination XL Group Financial Report 23rd of May 2024 PairCorr

Moving against PetMed Stock

  0.82DKS Dicks Sporting Goods Financial Report 28th of May 2024 PairCorr
  0.8WSM Williams Sonoma Financial Report 28th of May 2024 PairCorr
  0.68BBY Best Buy Sell-off TrendPairCorr
  0.66AN AutoNation Earnings Call This WeekPairCorr
  0.56LE Lands End Financial Report 6th of June 2024 PairCorr
  0.48HIBB Hibbett Sports TrendingPairCorr
  0.41KMX CarMax Inc Financial Report 28th of June 2024 PairCorr

PetMed Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. PetMed Express' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding PetMed Express or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
CEOMenderes Akdag
Thematic IdeaTrump Equities (View all Themes)
Business ConcentrationInternet & Direct Marketing Retail, Consumer Discretionary Distribution & Retail, Consumer Discretionary, NASDAQ Composite, NASDAQ Composite Total, Trump Equities, Consumer Discretionary, Internet & Direct Marketing Retail, Pharmaceutical Retailers, Healthcare (View all Sectors)
Average Analyst Recommendation
Analysts covering PetMed Express report their recommendations after researching PetMed Express' financial statements, talking to executives and customers, or listening in on PetMed Express' conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering PetMed Express. The PetMed consensus assessment is calculated by taking the average forecast from all of the analysts covering PetMed Express.
Financial Strength
Based on the key indicators related to PetMed Express' liquidity, profitability, solvency, and operating efficiency, PetMed Express may be sliding down financialy. It has an above-average risk of going through some form of financial straits next quarter. Financial strength of PetMed Express is based on its profitability, leverage, liquidity, source of funds, and operating efficiency.
Current ValueLast YearChange From Last Year 10 Year Trend
Asset Turnover3.161.8
Way Up
Slightly volatile
Gross Profit Margin0.40.32
Significantly Up
Slightly volatile
Total Current Liabilities44.1 M42 M
Sufficiently Up
Slightly volatile
Non Current Liabilities Total3.6 M3.4 M
Sufficiently Up
Pretty Stable
Total Assets198.2 M188.7 M
Sufficiently Up
Slightly volatile
Total Current Assets78 M151.2 M
Way Down
Slightly volatile
PetMed Express' financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to PetMed Express' success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit.
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand PetMed Express' financial leverage. It provides some insight into what part of PetMed Express' total assets is financed by creditors.
By using current balance sheet information, investors can analyze the liability, assets, and equity on PetMed Express' books and decide whether to invest or hold. Statistics such as return on equity (ROE), debt to equity (D/E) help investors determine how PetMed Express deploys its capital and how much of that capital is borrowed.
Liquidity
PetMed Express cash flow analysis is essential to understand how it generates and spends money over a specific period. It can also help you figure out where your money is going and how much cash you have available at a given moment. Debt To Equity is likely to drop to 0.01 in 2024The company has a current ratio of 5.5, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist PetMed Express until it has trouble settling it off, either with new capital or with free cash flow. So, PetMed Express' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like PetMed Express sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for PetMed to invest in growth at high rates of return. When we think about PetMed Express' use of debt, we should always consider it together with cash and equity.

Capital Expenditures

6.35 Million
PetMed Express (PETS) is traded on NASDAQ Exchange in USA. It is located in 420 South Congress Avenue, Delray Beach, FL, United States, 33445 and employs 302 people. PetMed Express is listed under Internet & Direct Marketing Retail category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 85.65 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate PetMed Express's market, we take the total number of its shares issued and multiply it by PetMed Express's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. PetMed Express conducts business under Internet & Direct Marketing Retail sector and is part of Consumer Discretionary industry. The entity has 21.15 M outstanding shares of which 4.9 M shares are at this time shorted by private and institutional investors with about 14.32 trading days to cover. PetMed Express currently holds about 105.41 M in cash with 27.8 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.21, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check PetMed Express Probability Of Bankruptcy
Ownership Allocation
PetMed Express owns a total of 21.15 Million outstanding shares. The majority of PetMed Express outstanding shares are owned by third-party entities. These institutional holders are usually referred to as non-private investors looking to secure positions in PetMed Express to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in PetMed Express. Please pay attention to any change in the institutional holdings of PetMed Express as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check PetMed Ownership Details

PetMed Stock Price Odds Analysis

Attributed to a normal probability distribution, the odds of PetMed Express jumping above the current price in 90 days from now is about 90.61%. The PetMed Express probability density function shows the probability of PetMed Express stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days PetMed Express has a beta of 0.8298 indicating as returns on the market go up, PetMed Express average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding PetMed Express will be expected to be much smaller as well. Additionally, petMed Express has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
  Odds Below 4.15HorizonTargetOdds Above 4.15
9.35%90 days
 4.15 
90.61%
Based on a normal probability distribution, the odds of PetMed Express to move above the current price in 90 days from now is about 90.61 (This PetMed Express probability density function shows the probability of PetMed Stock to fall within a particular range of prices over 90 days) .

PetMed Stock Institutional Holders

Institutional Holdings refers to the ownership stake in PetMed Express that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of PetMed Express' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing PetMed Express' value.
InstituionRecorded OnShares
State Street Corporation2023-12-31
453.1 K
Oaktop Capital Management Ii Lp2023-12-31
435.8 K
Charles Schwab Investment Management Inc2023-12-31
427 K
Qube Research & Technologies2023-12-31
355.9 K
Hrt Financial Llc2023-12-31
297 K
Aqr Capital Management Llc2023-12-31
271.4 K
Two Sigma Advisers, Llc2023-12-31
255.4 K
Allianz Asset Management Ag2023-12-31
250.3 K
Invenomic Capital Management, Lp2023-12-31
215.8 K
Blackrock Inc2023-12-31
1.8 M
Renaissance Technologies Corp2023-12-31
1.3 M
View PetMed Express Diagnostics

PetMed Express Historical Income Statement

PetMed Express Income Statement is one of the three primary financial statements used for reporting PetMed's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of PetMed Express revenue and expense. PetMed Express Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, PetMed Express' Depreciation And Amortization is comparatively stable compared to the past year. Interest Expense is likely to gain to about 3.6 M in 2024, whereas Gross Profit is likely to drop slightly above 71.6 M in 2024. View More Fundamentals

PetMed Stock Against Markets

Picking the right benchmark for PetMed Express stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in PetMed Express stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for PetMed Express is critical whether you are bullish or bearish towards PetMed Express at a given time. Please also check how PetMed Express' historical prices are related to one of the top price index indicators.

Be your own money manager

Our tools can tell you how much better you can do entering a position in PetMed Express without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Sectors Now

   

Sectors

List of equity sectors categorizing publicly traded companies based on their primary business activities
All  Next Launch Module

PetMed Express Corporate Directors

PetMed Express corporate directors refer to members of a PetMed Express board of directors. The board of directors generally takes responsibility for the PetMed Express' affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of PetMed Express' board members must vote for the resolution. The PetMed Express board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.
Ronald KornIndependent DirectorProfile
Frank FormicaIndependent DirectorProfile
Leslie CampbellIndependent DirectorProfile
Gian FulgoniIndependent DirectorProfile

How to buy PetMed Stock?

Before investing in PetMed Express, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in PetMed Express. To buy PetMed Express stock, you can follow these steps:
  • Choose a brokerage firm: You need to select a brokerage firm to buy shares of PetMed Express. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
  • Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
  • Fund your account: You will need to deposit funds into your brokerage account to purchase PetMed Express stock. You can do this by transferring funds from your bank account or other investment accounts.
  • Place your order: Once you have located PetMed Express stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
  • Monitor your investment: After you have purchased PetMed Express stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as PetMed Express, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy PetMed Stock please use our How to Invest in PetMed Express guide.

Already Invested in PetMed Express?

The danger of trading PetMed Express is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of PetMed Express is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than PetMed Express. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile PetMed Express is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether PetMed Express is a strong investment it is important to analyze PetMed Express' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact PetMed Express' future performance. For an informed investment choice regarding PetMed Stock, refer to the following important reports:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in PetMed Express. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate.
For more information on how to buy PetMed Stock please use our How to Invest in PetMed Express guide.
You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.

Complementary Tools for PetMed Stock analysis

When running PetMed Express' price analysis, check to measure PetMed Express' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PetMed Express is operating at the current time. Most of PetMed Express' value examination focuses on studying past and present price action to predict the probability of PetMed Express' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PetMed Express' price. Additionally, you may evaluate how the addition of PetMed Express to your portfolios can decrease your overall portfolio volatility.
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Is PetMed Express' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of PetMed Express. If investors know PetMed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about PetMed Express listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.59)
Dividend Share
0.9
Earnings Share
(0.37)
Revenue Per Share
13.599
Quarterly Revenue Growth
0.11
The market value of PetMed Express is measured differently than its book value, which is the value of PetMed that is recorded on the company's balance sheet. Investors also form their own opinion of PetMed Express' value that differs from its market value or its book value, called intrinsic value, which is PetMed Express' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because PetMed Express' market value can be influenced by many factors that don't directly affect PetMed Express' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between PetMed Express' value and its price as these two are different measures arrived at by different means. Investors typically determine if PetMed Express is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, PetMed Express' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.